Ambu A/S (CPH:AMBU.B)
Denmark · Delayed Price · Currency is DKK 70.50
+0.35 (0.50%)
Aug 28, 2026, 4:59 PM CET
Ambu A/S Market Cap
Ambu A/S has a market cap or net worth of 18.6 billion as of August 28, 2026. Its market cap has decreased by -28.60% in one year.
Market Cap
18.60B
Enterprise Value
18.47B
Revenue
6.24B
Ranking
n/a
PE Ratio
36.73
Stock Price
70.50
ChartMarket Cap Chart
Since August 8, 1994, Ambu A/S's market cap has increased from 290.04M to 18.60B, an increase of 6,313.25%. That is a compound annual growth rate of 13.85%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 28, 2026 | 18.60B | -20.57% |
| Dec 30, 2025 | 23.42B | -15.47% |
| Dec 30, 2024 | 27.70B | -1.11% |
| Dec 29, 2023 | 28.01B | 23.89% |
| Dec 30, 2022 | 22.61B | -48.49% |
| Dec 30, 2021 | 43.90B | -32.73% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Novo Nordisk | 1.31T |
| Genmab | 128.72B |
| Coloplast | 104.19B |
| Demant | 60.19B |
| ALK-Abelló | 46.28B |
| H. Lundbeck | 40.98B |
| Zealand Pharma | 21.31B |
| Bavarian Nordic | 16.15B |